Microscopy & Microtechniques
Easing the way for pain-free insulin injections
Mar 13 2006
Author: Matthew Williamson, Novo Nordisk and Chris Keeping on behalf of Novo Nordisk A/S
There are an estimated 194 million diabetics worldwide and at the present rate of growth, this figure will exceed 333 million by 2025 [1]. Since some 17 million of the 194 million suffer from Type 1 diabetes and rely on regular injections of insulin, there is continuous effort by manufacturers of insulin delivery devices and needles to minimise the pain associated with these vital injections. Materials testing methods have an important role in ensuring that needles and needle assemblies meet the needs for safe handling and easy, pain-free injection.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan
